Skip to content

APOTHEEK AMERY

Active
Private limited companyfounded 1984active for 42 yearsKerkstraat 5, 8620 Nieuwpoort, BelgiumKBO/BCE: BE 0425.481.590

From the official registers: KBO 42 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

APOTHEEK AMERY has been active since 1984 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €227,240 and a net result of €15,410. Equity is shrinking by about 13% per year and would, assuming unchanged policy, indicatively turn negative around financial year 2027. Its solvency ranks better than 58% of 12,757 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.5% (low).

Risk analysisFollow ReportCompare
APOTHEEK AMERYActiveChecked score 81/100
Risk analysis ReportCompare

Overview

Official details

KBO
Status
Active since 29-02-1984 Normal situation
Legal form
Private limited company
Registered office
Kerkstraat 5, 8620 Nieuwpoort
Activity
Retail sale of pharmaceutical products NACE 47730
Establishment unit
2.024.286.961 8620 Nieuwpoort, since 29-02-1984
Financial year end
31 December
Peppol
Reachable since 06-06-2025
Company details

Who decides

Board
  • ALEXOChair · permanent representative Olivier Delaere
  • BV SODIAPManaging director · permanent representative Tom Goderis
  • BV KST PharmaDirector · permanent representative Koen Straetmans
Shareholders
Board & ownership

How it is doing

81 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.5%
Annual accounts 2025
Gross margin
€222,342
▼ 32.5%
Turnover
≈ €1.0m
estimated
Profit
€15,410
▼ 74.4%
Equity
€227,240
▲ 7.3%
Total assets
€514,486
▼ 3.4%
Staff
1.8 FTE
▼ 35.7%
2025 accounts 80 days early
Filed on 12-05-2026PDF
Financials
Why 81raises riskSector: Retail trade (NACE 47)Liquidity: current ratio 1.06, cash €7,760Size: 1.8 FTE, total assets €514,486lowers riskFounded in 1984Show the evidence

Checked score

Score 2025
81 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 48% of its sector peers (NACE 47, micro)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Average
Solvency 69+4
equity 44.2% of total assets
Liquidity 23+2
short-term debt 55.8% · cash 1.5%
Profitability 72-11
return on assets 3.0%
Bankruptcy probability, 12 months
0.5% Low
0%0.5%1.5%4%10%≥ 25%

About 5 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,270 companies, NACE 47, micro)
Last 24 months 11-2024: 0.4% 12-2024: 0.4%● unchanged vs 11-2024 01-2025: 0.4%● unchanged vs 12-2024 02-2025: 0.4%● unchanged vs 01-2025 03-2025: 0.4%● unchanged vs 02-2025lowest value 04-2025: 0.4%● unchanged vs 03-2025 05-2025: 0.4%● unchanged vs 04-2025 06-2025: 0.5%▲ +0.1 percentage points vs 05-2025 07-2025: 0.4%▼ -0.1 percentage points vs 06-2025 08-2025: 0.4%● unchanged vs 07-2025 09-2025: 0.4%● unchanged vs 08-2025 10-2025: 0.4%● unchanged vs 09-2025 11-2025: 0.4%● unchanged vs 10-2025 12-2025: 0.4%● unchanged vs 11-2025 01-2026: 0.4%● unchanged vs 12-2025 02-2026: 0.4%● unchanged vs 01-2026 03-2026: 0.4%● unchanged vs 02-2026 04-2026: 0.4%● unchanged vs 03-2026 05-2026: 0.5%▲ +0.1 percentage points vs 04-2026 06-2026: 0.5%● unchanged vs 05-2026highest value 07-2026: 0.5%● unchanged vs 06-2026highest value 08-2026: 0.5%● unchanged vs 07-2026highest value 09-2026: 0.5%● unchanged vs 08-2026highest value 10-2026: 0.5%● unchanged vs 09-2026highest value
Credit of up to €18,000 on 30-day terms is acceptable
Liquidity tight (current ratio 1.06, compared with 0.92 in 2024, below the usual 1.5; short-term debt: 55.8% and cash: 1.5% of total assets), and 55.8% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 59% on solvency, 21% on liquidity, 56% on profitability and 56% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
raises risk · Sector: Retail trade (NACE 47)
KBO
lowers risk · Founded in 1984
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
raises risk · Liquidity: current ratio 1.06, cash €7,760
NBB · annual accounts
raises risk · Size: 1.8 FTE, total assets €514,486
Companies of this size fail more often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year €227,240
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 12-05-2026, 80 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
80 days early
2024
45 days early
2023
50 days early
2022
52 days early
2021
54 days early
2020
47 days early
2019
24 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 50 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 9 June (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage

Key points

  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
  • Positive: 8 profitable years in a rowprofit 2025: €15,410 8 years View
  • New directorlatest change 19-05-2026 · 2 in office 1 joined View

Documents

Annual accounts at the NBB

All 42 annual accounts

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about APOTHEEK AMERY

What is the company number of APOTHEEK AMERY?
0425.481.590. In Belgium the VAT number is the company number with BE in front: BE 0425.481.590.
Where is APOTHEEK AMERY based?
The registered office is at Kerkstraat 5, 8620 Nieuwpoort.Company details
What does APOTHEEK AMERY do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK AMERY?
Private limited company (BV).
When was APOTHEEK AMERY founded?
On 29-02-1984.
Is APOTHEEK AMERY still active?
Yes, APOTHEEK AMERY is an active enterprise in the KBO register.
How many employees does APOTHEEK AMERY have?
On average 1.8 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of APOTHEEK AMERY?
≈ €1.0m in financial year 2025. Estimated from the gross margin of €222,342: probably between €700,000 and €2.0m, based on 51 comparable companies, NACE 477.
Is APOTHEEK AMERY profitable?
In financial year 2025, APOTHEEK AMERY made a profit of €15,410.
Where can I find the annual accounts of APOTHEEK AMERY?
APOTHEEK AMERY filed 42 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)
When are the next annual accounts of APOTHEEK AMERY due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to APOTHEEK AMERY

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What support did similar companies receive that this one did not?Subsidies Which other companies belong to the same group?PHARMACIE BIA · 40 companies

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure